Literature DB >> 4544619

Thymus-dependent lymphocytes of peripheral blood in leprosy patients.

S D Lim, D F Kiszkiss, R R Jacobson, Y S Choi, R A Good.   

Abstract

Study of the numbers of thymus-derived lymphocytes by the rosette assay (T-RFC) in patients with leprosy reveals that lower than normal numbers of T-RFC are regularly seen in those patients with the active lepromatous form of this disease. Essentially normal numbers of T-RFC were found in inactive lepromatous, borderline, and indeterminate types of leprosy. The lowest percentages and lowest absolute numbers of T-RFC were encountered in patients with lepromatous leprosy resistant to chemotherapy. Patients with lepromatous leprosy complicated by erythema nodosum leprosum show numbers of T-RFC that are more nearly normal than the numbers of T-RFC in patients with uncomplicated lepromatous leprosy. These findings are discussed with respect to the pathogenesis of lepromatous leprosy and the T-RFC deficiency demonstrated in this disease. The possibility that transient defects in T-RFC numbers or function may predispose to lepromatous leprosy is proposed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4544619      PMCID: PMC414815          DOI: 10.1128/iai.9.2.394-399.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Impaired delayed hypersensitivity in patients with lepromatous leprosy.

Authors:  D S Waldorf; J N Sheagren; J R Trautman; J B Block
Journal:  Lancet       Date:  1966-10-08       Impact factor: 79.321

2.  Immunological basis for depression of cellular immunity and the delayed allergic response in patients with lepromatous leprosy.

Authors:  J L Turk; M F Waters
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

3.  Enhancing effect of antilymphocytic serum on mycobacterial infections in mice.

Authors:  J Gaugas; R J Rees
Journal:  Nature       Date:  1968-07-27       Impact factor: 49.962

4.  Cell-mediated immunity in patients with leprosy.

Authors:  J L Turk; M F Waters
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

5.  Enhancing effect of antilymphocytic globulin on human leprosy infection in thymectomized mice.

Authors:  J M Gaugas
Journal:  Nature       Date:  1968-12-21       Impact factor: 49.962

6.  Experimental lepromatous leprosy.

Authors:  R J Rees; M F Waters; A G Weddell; E Palmer
Journal:  Nature       Date:  1967-08-05       Impact factor: 49.962

7.  Effect of phytohemagglutinin and various mycobacterial antigens on lymphocyte cultures from leprosy patients.

Authors:  R E Dierks; C C Shepard
Journal:  Proc Soc Exp Biol Med       Date:  1968-02

8.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

9.  The etiology of erythema nodosum leprosum.

Authors:  J H Pettit; M F Waters
Journal:  Int J Lepr Other Mycobact Dis       Date:  1967 Jan-Mar

10.  Studies on sulfone resistance in leprosy. I. Detection of cases.

Authors:  J H Pettit; R J Rees; D S Ridley
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Oct-Dec
View more
  11 in total

Review 1.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

2.  Studies on the subpopulation and function of peripheral lymphocytes, and inhibitor to PHA stimulation existing in the serum of patients with liver disease.

Authors:  M Nakao; Y Mizoguchi; T Monna; S Yamamoto; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1975

3.  T and CR+ lymphocyte profile in leprosy and the effect of treatment.

Authors:  R Sher; G Holm; S H Kok; H J Koornhof; A Glover
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

4.  Effect of levamisole on Mycobacterium leprae in mice.

Authors:  C C Shepard; R Van Landingham; L L Walker
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

5.  Antibody-mediated immunity in CFW mice infected with Mycobacterium lepraemurium. Humoral immune response in murine leprosy.

Authors:  O Rojas-Espinosa; M Casoluengo-Méndez; G V Díaz
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

6.  Cytogenetic studies in leprosy patients before and after chemotherapy.

Authors:  D D'Souza; B C Das; I M Thomas
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

7.  Circulating T-cell numbers and their mitogenic potential in leprosy--correlation with mycobacterial load.

Authors:  I Nath; J Curtis; A K Sharma; G P Talwar
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

8.  Effect of Mycobacterium leprae on lymphocyte proliferation: suppression of mitogen and antigen responses of human peripheral blood mononuclear cells.

Authors:  J Touw; G L Stoner; A Belehu
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

9.  Mechanism of immunosuppression in leprosy: presence of suppressor factor(s) from macrophages of lepromatous patients.

Authors:  P R Salgame; P R Mahadevan; N H Antia
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

10.  Cell-mediated immunity in amyloidosis secondary to lepromatous leprosy.

Authors:  E M Anders; K P McAdam; R F Anders
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.